Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

National MS Society: Sylvia Lawry Physician Fellowships
Episode 23 with Professor Aksel Siva discussing radiologically isolated syndrome (RIS)
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
GlaxoSmithKline Protocol Summaries: Firategrast
IL-17 and Th17 Cells.
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
The natural history of primary progressive MS in British Columbia, Canada.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Testosterone treatment in multiple sclerosis: a pilot study.
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis.
The relevance of animal models in multiple sclerosis research.
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Clinical Trials
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Sex ratio of multiple sclerosis and clinical phenotype.
Neurodegeneration: From Multiple Sclerosis to Alzheimer’s Disease
Summit 2013 + Expo
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.

Pages